Significance of Oligomeric and Fibrillar Species in Amyloidosis: Insights into Pathophysiology and Treatment
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Significance of Oligomeric and Fibrillar Species in Amyloidosis: Insights into Pathophysiology and Treatment
Authors
Keywords
-
Journal
MOLECULES
Volume 26, Issue 16, Pages 5091
Publisher
MDPI AG
Online
2021-08-23
DOI
10.3390/molecules26165091
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Two distinct mechanisms of neuropathy in immunoglobulin light chain (AL) amyloidosis
- (2021) Haruki Koike et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Membrane Interactions and Toxicity by Misfolded Protein Oligomers
- (2021) Mario Gonzalez-Garcia et al. Frontiers in Cell and Developmental Biology
- The release of toxic oligomers from α-synuclein fibrils induces dysfunction in neuronal cells
- (2021) Roberta Cascella et al. Nature Communications
- A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody
- (2021) Chad J. Swanson et al. Alzheimers Research & Therapy
- Multidisciplinary Approaches for Transthyretin Amyloidosis
- (2021) Haruki Koike et al. Cardiology and Therapy
- A mechanistic hypothesis for the impairment of synaptic plasticity by soluble Ab oligomers from Alzheimer brain
- (2020) Shaomin Li et al. JOURNAL OF NEUROCHEMISTRY
- Acquired and inherited amyloidosis: knowledge driving patients’ care
- (2020) Laura Obici et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Disruption of the CD Loop by Enzymatic Cleavage Promotes the Formation of Toxic Transthyretin Oligomers through a Common Transthyretin Misfolding Pathway
- (2020) Anvesh K. R. Dasari et al. BIOCHEMISTRY
- Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study
- (2020) David Adams et al. LANCET NEUROLOGY
- Ligand conjugated antisense oligonucleotide for the treatment of transthyretin amyloidosis: preclinical and phase 1 data
- (2020) Nicholas J. Viney et al. ESC Heart Failure
- Transthyretin Aggregation Pathway toward the Formation of Distinct Cytotoxic Oligomers
- (2019) Anvesh K. R. Dasari et al. Scientific Reports
- Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease
- (2019) David Adams et al. Nature Reviews Neurology
- Cellular Prion Protein as a Receptor of Toxic Amyloid-β42 Oligomers Is Important for Alzheimer’s Disease
- (2019) Yuan Zhang et al. Frontiers in Cellular Neuroscience
- Co-activation of selective nicotinic acetylcholine receptors is required to reverse beta amyloid-induced Ca2+ hyperexcitation
- (2019) Julianna L. Sun et al. NEUROBIOLOGY OF AGING
- Inotersen preserves or improves quality of life in hereditary transthyretin amyloidosis
- (2019) Teresa Coelho et al. JOURNAL OF NEUROLOGY
- Crucial role of protein oligomerization in the pathogenesis of Alzheimer's and Parkinson's diseases
- (2018) Minee L. Choi et al. FEBS Journal
- Plasminogen activation triggers transthyretin amyloidogenesisin vitro
- (2018) P. Patrizia Mangione et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
- (2018) David Adams et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
- (2018) Merrill D. Benson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease
- (2018) Lawrence S. Honig et al. NEW ENGLAND JOURNAL OF MEDICINE
- The morphology of amyloid fibrils and their impact on tissue damage in hereditary transthyretin amyloidosis: An ultrastructural study
- (2018) Haruki Koike et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Cellular and Molecular Mechanisms of Prion Disease
- (2018) Christina J. Sigurdson et al. Annual Review of Pathology-Mechanisms of Disease
- Serum amyloid A forms stable oligomers that disrupt vesicles at lysosomal pH and contribute to the pathogenesis of reactive amyloidosis
- (2017) Shobini Jayaraman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
- (2017) Susanne Ostrowitzki et al. Alzheimers Research & Therapy
- The amyloid hypothesis of Alzheimer's disease at 25 years
- (2016) Dennis J Selkoe et al. EMBO Molecular Medicine
- Systemic amyloidosis
- (2016) Ashutosh D Wechalekar et al. LANCET
- Alzheimer's disease
- (2016) Philip Scheltens et al. LANCET
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2016) Jeff Sevigny et al. NATURE
- Schwann cell and endothelial cell damage in transthyretin familial amyloid polyneuropathy
- (2016) Haruki Koike et al. NEUROLOGY
- Binding affinity of amyloid oligomers to cellular membranes is a generic indicator of cellular dysfunction in protein misfolding diseases
- (2016) Elisa Evangelisti et al. Scientific Reports
- Targeting protein aggregation for the treatment of degenerative diseases
- (2015) Yvonne S. Eisele et al. NATURE REVIEWS DRUG DISCOVERY
- The physical chemistry of the amyloid phenomenon: thermodynamics and kinetics of filamentous protein aggregation
- (2014) Alexander K. Buell et al. Essays in Biochemistry
- Marked and Rapid Regression of Hepatic Amyloid Deposition in a Patient with Systemic Light Chain (AL) Amyloidosis after High-dose Melphalan Therapy with Stem Cell Transplantation
- (2014) Nagaaki Katoh et al. INTERNAL MEDICINE
- Steady turnover of amyloid fibril proteins in gastric mucosa after liver transplantation in familial amyloid polyneuropathy
- (2013) Ayako Tsuchiya-Suzuki et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Natural history of transthyretin Val30Met familial amyloid polyneuropathy: analysis of late-onset cases from non-endemic areas
- (2012) Haruki Koike et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
- (2012) Iryna Benilova et al. NATURE NEUROSCIENCE
- Formation of immunoglobulin light chain amyloid oligomers in primary cutaneous nodular amyloidosis
- (2011) A.L. Clos et al. BRITISH JOURNAL OF DERMATOLOGY
- Amyloid oligomers: dynamics and toxicity in the cytosol and nucleus
- (2010) Akira Kitamura et al. FEBS Journal
- N-Methyl-d-aspartate receptors are required for synaptic targeting of Alzheimer’s toxic amyloid-β peptide oligomers
- (2010) Helena Decker et al. JOURNAL OF NEUROCHEMISTRY
- A Mouse Model of Amyloid Oligomers: Their Contribution to Synaptic Alteration, Abnormal Tau Phosphorylation, Glial Activation, and Neuronal Loss In Vivo
- (2010) T. Tomiyama et al. JOURNAL OF NEUROSCIENCE
- Systemic amyloidosis: a challenge for the rheumatologist
- (2010) Federico Perfetto et al. Nature Reviews Rheumatology
- An Update on Nerve Biopsy
- (2009) Jean-Michel Vallat et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers
- (2009) Juha Laurén et al. NATURE
- A new amyloid β variant favoring oligomerization in Alzheimer's-type dementia
- (2008) Takami Tomiyama et al. ANNALS OF NEUROLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started